Volume 27, Issue 10 pp. 1382-1391
Original Article

The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated Hepatitis

Jessica A. Musto

Jessica A. Musto

Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI

Search for more papers by this author
Jens Eickhoff

Jens Eickhoff

Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI

Search for more papers by this author
Meritxell Ventura-Cots

Meritxell Ventura-Cots

University of Pittsburgh Medical Center, Pittsburgh, PA

Liver Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain

Search for more papers by this author
Juan G. Abraldes

Juan G. Abraldes

Division of Gastroenterology, Liver Unit, University of Alberta, Edmonton, AB, Canada

Search for more papers by this author
Francisco Bosques-Padilla

Francisco Bosques-Padilla

Hospital Universitario, Departamento de Gastroenterología, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico

Search for more papers by this author
Elizabeth C. Verna

Elizabeth C. Verna

Division of Digestive and Liver Diseases, Department of Medicine, Columbia College of Physicians and Surgeons, Columbia University Medical Center, New York, NY

Search for more papers by this author
Robert S. Brown Jr.

Robert S. Brown Jr.

Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY

Search for more papers by this author
Victor Vargas

Victor Vargas

Liver Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain

Search for more papers by this author
Jose Altamirano

Jose Altamirano

Liver Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

Search for more papers by this author
Juan Caballería

Juan Caballería

Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain

Liver Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain

Search for more papers by this author
Debbie Shawcross

Debbie Shawcross

Institute of Liver Studies, King's College London School of Medicine at King's College Hospital, King's College Hospital, London, United Kingdom

Search for more papers by this author
Alexandre Louvet

Alexandre Louvet

Service des Maladies de L'appareil Digestif et Unité INSERM, Hôpital Huriez, Lille, France

Search for more papers by this author
Philippe Mathurin

Philippe Mathurin

Service des Maladies de L'appareil Digestif et Unité INSERM, Hôpital Huriez, Lille, France

Search for more papers by this author
Guadalupe Garcia-Tsao

Guadalupe Garcia-Tsao

Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT

Section of Digestive Diseases, VA-CT Healthcare System, West Haven, CT

Search for more papers by this author
Bernd Schnabl

Bernd Schnabl

UC San Diego, San Diego, CA

Search for more papers by this author
Ramon Bataller

Ramon Bataller

University of Pittsburgh Medical Center, Pittsburgh, PA

Search for more papers by this author
Michael R. Lucey

Corresponding Author

Michael R. Lucey

Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI

Address reprint requests to Michael R. Lucey, M.D., F.R.C.P.I., F.A.A.S.L.D., University of Wisconsin School of Medicine and Public Health, Room 4245, UW Medical Foundation Centennial Building, 1685 Highland Avenue, Madison, WI 53705-2281. Telephone: 608-263-7322; FAX : 608-265-5677; E-mail: [email protected]

Search for more papers by this author
First published: 10 June 2021
Citations: 1

This study was supported by National Institutes of Health U01 AA026939.

Michael R. Lucey advises for Novartis (member of DSMB) and has grants with Pharmasolutions. Bernd Schnabl has stock in Nterica Bio; consults for Ferring Research Institute, Mabwell Therapeutics, and Takeda; and has grants with Axial Biotherapeutics, BiomX, CymaBay Therapeutics, Prodigy Biotech, and Synlogic Operating Company.

Abstract

The 10-item Alcohol Use Disorders Identification Test (AUDIT-10) and its shorter form, AUDIT-Consumption (AUDIT-C), are questionnaires used to characterize severity of drinking. We hypothesized that liver injury and short-term outcomes of alcohol-associated hepatitis (AH) would correlate with a patient’s recent alcohol consumption as determined by AUDIT-10 and AUDIT-C. We analyzed a prospective international database of patients with AH diagnosed based on the National Institute on Alcohol Abuse and Alcoholism (NIAAA) standard definitions. All patients were interviewed using AUDIT-10. Primary outcomes included the discriminatory ability of the AUDIT-10 and AUDIT-C scores for predicting survival status at 28 and 90 days and severity of liver injury, as measured by Model for End-Stage Liver Disease–sodium (MELD-Na). The relationship between AUDIT scores and survival status was quantified by calculating the area under the curve of the receiver operating characteristic analysis. The relationship between AUDIT scores and MELD-Na was examined using correlation coefficients. In 245 patients (age range 25-75 years; 35% female), we found no correlation between AUDIT-10 or AUDIT-C scores and either 28- or 90-day mortality. Similarly, there was no correlation between AUDIT-10 and AUDIT-C and MELD-Na scores. There was a strong positive correlation between MELD-Na and 28- and 90-day mortality. Additional measures of severity of alcohol use (average grams of alcohol consumed per day, years of drinking, convictions for driving under the influence, and rehabilitation attempts) and psychosocial factors (marriage, paid employment, and level of social support) had no influence on MELD-Na. In patients presenting with AH, AUDIT-10 and AUDIT-C were predictors of neither clinical severity of liver disease nor short-term mortality, suggesting that level of alcohol consumption in the prior year is not key to the presenting features or outcome of AH.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.